Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Rueda

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2014
Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patientsFrancisco Ortiz-Sanjuán, Ricardo Blanco, Vanesa Calvo-Rio, et al.
Nature|April 22, 2026
Focal white matter lesions drive grey matter inflammation and synapse lossOmar de Faria, Stavros Vagionitis, Andrea Lopez-Lopez, et al.
Seminars in Arthritis and Rheumatism|June 11, 2022
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patientsJavier Rueda-Gotor, Iván Ferraz-Amaro, Fernanda Genre, et al.
RMD Open|June 28, 2024
Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patientsIvan Ferraz-Amaro, Fernanda Genre, Ricardo Blanco, et al.
Seminars in Arthritis and Rheumatism|September 23, 2022
Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patientsJavier Rueda-Gotor, Iván Ferraz-Amaro, Fernanda Genre, et al.
Science (New York, N.Y.)|July 9, 2026
C1q and immunoglobulins mediate activity-dependent synapse loss in the adult brainGerard Crowley, Minjung Kim, Nathanael O'Neill, et al.
Arthritis Research & Therapy|April 14, 2021
Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological studyJavier Rueda-Gotor, Raquel López-Mejías, Sara Remuzgo-Martínez, et al.
Seminars in Arthritis and Rheumatism|February 19, 2021
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patientsIñigo González Mazón, Javier Rueda-Gotor, Iván Ferraz-Amaro, et al.
Seminars in Arthritis and Rheumatism|April 14, 2023
Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patientsIván Ferraz-Amaro, Fernanda Genre, Ricardo Blanco, et al.
Frontiers in Immunology|July 28, 2022
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial SpondyloarthritisSara Remuzgo-Martínez, Javier Rueda-Gotor, Verónica Pulito-Cueto, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2014
Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patientsFrancisco Ortiz-Sanjuán, Ricardo Blanco, Vanesa Calvo-Rio, et al.
Nature|April 22, 2026
Focal white matter lesions drive grey matter inflammation and synapse lossOmar de Faria, Stavros Vagionitis, Andrea Lopez-Lopez, et al.
Seminars in Arthritis and Rheumatism|June 11, 2022
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patientsJavier Rueda-Gotor, Iván Ferraz-Amaro, Fernanda Genre, et al.
RMD Open|June 28, 2024
Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patientsIvan Ferraz-Amaro, Fernanda Genre, Ricardo Blanco, et al.
Seminars in Arthritis and Rheumatism|September 23, 2022
Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patientsJavier Rueda-Gotor, Iván Ferraz-Amaro, Fernanda Genre, et al.
Science (New York, N.Y.)|July 9, 2026
C1q and immunoglobulins mediate activity-dependent synapse loss in the adult brainGerard Crowley, Minjung Kim, Nathanael O'Neill, et al.
Arthritis Research & Therapy|April 14, 2021
Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological studyJavier Rueda-Gotor, Raquel López-Mejías, Sara Remuzgo-Martínez, et al.
Seminars in Arthritis and Rheumatism|February 19, 2021
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patientsIñigo González Mazón, Javier Rueda-Gotor, Iván Ferraz-Amaro, et al.
Seminars in Arthritis and Rheumatism|April 14, 2023
Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patientsIván Ferraz-Amaro, Fernanda Genre, Ricardo Blanco, et al.
Frontiers in Immunology|July 28, 2022
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial SpondyloarthritisSara Remuzgo-Martínez, Javier Rueda-Gotor, Verónica Pulito-Cueto, et al.
Pageof 10